Illinois has long been recognized as a center of innovation and growth, particularly in the bio manufacturing industry. The state’s commitment to fostering a supportive business environment, coupled with its highly skilled workforce and world-class research institutions, has attracted numerous companies to establish operations in Illinois.

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), recently announced plans to expand its operations in the state, further cementing Illinois’ position as a leader in the bio manufacturing sector. The company’s decision to relocate and expand its Development Services site from Skokie to Des Plaines will effectively double its capacity in the U.S., providing ample space for future growth.

The new facility in Des Plaines will feature state-of-the-art buildings for clinical manufacturing and related services, showcasing Illinois’ dedication to providing cutting-edge resources and expertise to companies in the life sciences industry. This commitment to innovation is evident in the numerous research institutions and collaborative environments found throughout the state, such as the Illinois Science and Technology Park, where Vetter’s current Skokie site is located.

CBRE Ranks Chicago Third in the Country for Biomanufacturing

In a recent report released by CBRE, Chicago was ranked third in the country for bio manufacturing, highlighting the city’s strength in the life sciences workforce. Despite the challenges posed by historically low U.S. unemployment rates, Illinois’ thriving life sciences ecosystem continues to attract top R&D and manufacturing talent.

This recognition underscores Illinois’ position as a leader in the bio manufacturing industry and demonstrates the state’s ability to provide a robust talent pool for companies looking to establish or expand their operations in the region.

Focusing State Economic Incentives to Support Biomanufacturing Growth

To maintain and accelerate the growth of biomanufacturing in Illinois, it is crucial for the state to focus its economic incentives on supporting this industry. One example of such an incentive is to make the state’s R&D Tax Credit transferable. This would allow smaller companies that may not be able to utilize the credit to sell it to larger companies that can immediately benefit from it. This win-win situation has already proven successful in other states and could be a significant driver of growth in Illinois’ bio manufacturing sector.

By implementing targeted economic incentives, Illinois can create an even more attractive environment for companies looking to invest in biomanufacturing. These incentives not only support the growth of existing companies but also encourage new businesses to establish roots in the state, further strengthening Illinois’ position as a leader in the industry.

John Conrad, President and CEO of the Illinois Biotechnology Innovation Organization, emphasized the state’s potential, stating, “Illinois has all of the ingredients to support the growth of biomanufacturing in the state. We have a great workforce, leading academic institutions, a thriving industry, and we are centrally located with access to multiple modes of transportation.”

Illinois’ Potential for Continued Biomanufacturing Growth

Vetter’s commitment to grow in Illinois is a testament to the vast opportunities that exist within the state and the region. As the demand for complex injectables and other advanced therapies continues to rise, CDMOs like Vetter are increasingly sought after by pharmaceutical companies looking to outsource their development and manufacturing needs.

Illinois is well-positioned to capitalize on this growing demand, thanks to its robust infrastructure and talented workforce. The state’s commitment to education and workforce development ensures a steady supply of skilled professionals ready to drive innovation in the bio manufacturing sector. Vetter has long leveraged programs like Illinois’ manufacturing apprenticeship program to attract and train qualified employees. Additionally, Illinois’ strategic location and well-developed transportation network make it an attractive destination for companies seeking to establish or expand their operations.

As more companies recognize the advantages of setting up operations in Illinois, the state is likely to experience continued growth and investment in the bio manufacturing industry. This growth will not only create new job opportunities but also drive economic development and further solidify Illinois’ reputation as a global leader in life sciences innovation.

This article was originally published on iBIO NewsBrief. Gain a head start on your day with iBIO NewsBrief. Subscribe to receive top industry headlines delivered straight to your inbox.